Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

Prader-Willi Hyperphagia Publication Reframes Assessment and Care

Experts recast hyperphagia in Prader-Willi syndrome as a complex neurobehavioral disorder, with implications for assessment, multidisciplinary care, and treatment.

By Dr. A. Nikhil Krishnan, MBBS · Oct 24, 2026 · 5 min read

Endocrinology·ClinicalTrials

Insulin Vascular Study Targets Obesity-Related Muscle Malperfusion

An early-phase study will test whether intra-arterial insulin alters forearm blood flow in obesity and insulin resistance versus…

Oct 23, 2026

Endocrinology·BMJ

RPM Transitional Care Improves Diabetes Follow-up After Hospital Discharge

A quality improvement initiative used remote glucose monitoring to extend transitional care after discharge for adults with poorly…

Oct 23, 2026

Endocrinology·DailyMed

Dapagliflozin-Metformin ER Label Adds Renal, HF, and Pediatric Guidance

DailyMed updated the dapagliflozin-metformin ER label with boxed lactic acidosis warning, renal limits, pediatric use, and perioperative precautions.

Oct 23, 2026

Endocrinology·medRxiv

Poor Glycaemic Control in Kenyan Children With Type 1 Diabetes Under Review

A Kenyan preprint examines factors linked to poor glycaemic control in children and adolescents with type 1 diabetes…

Oct 23, 2026

Endocrinology·medRxiv

Type 2 Diabetes Remission Is Rare and Often Ends With Treatment Restart

Linked health records show type 2 diabetes remission is uncommon, brief, and more often followed by treatment restart…

Oct 23, 2026

Endocrinology·BMJ Open

Moxibustion for PCOS: BMJ Open protocol sets meta-analysis endpoints

BMJ Open protocol will review randomized trials of moxibustion for PCOS, focusing on ovulation, pregnancy, hormones, metabolism, and…

Oct 23, 2026

Endocrinology·Cancer Cell

Acupuncture for Prediabetes Gains Support in Mechanistic Review

A 2026 review in International Journal of General Medicine examines acupuncture and moxibustion for prediabetes, including metabolic effects…

Oct 23, 2026

Endocrinology·medRxiv

Linafexor with Low-Dose Semaglutide Studied for Obesity and MASH

A medRxiv preprint evaluates whether the FXR agonist linafexor can augment low-dose semaglutide for weight loss in obesity,…

Oct 23, 2026

Endocrinology·Sci Transl Med

Amino Acids Emerge as Biomarkers for Type 2 Diabetes Prediction

A review in Metabolites examines amino acids as biomarkers for insulin resistance and type 2 diabetes, with implications…

Oct 23, 2026

Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.